AMRN

Amarin Corporation PLC News Headlines

$1.05
*  
0.02
1.94%
Get AMRN Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading AMRN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Amarin Corporation (AMRN) in Focus: Stock Moves Higher by 8% - Analyst Blog
9/6/2013 7:51:52 AM - Zacks.com


Updated Vascepa Data And Why I Would Buy Into Amarin's Current Momentum
9/5/2013 11:12:00 AM - Seeking Alpha


Amarin Regains Ahead Of Vital Q4 Catalysts
9/4/2013 12:07:00 PM - Seeking Alpha


3 Biotech Products To Watch Over The Next Year
9/4/2013 10:03:00 AM - Seeking Alpha


Can the Recent Uptrend Continue for Amarin Corporation plc (AMRN)? - Tale of the Tape
8/27/2013 5:34:21 AM - Zacks.com


Amarin Heading In The Right Direction Based On Script Data Trends
8/26/2013 11:34:00 AM - Seeking Alpha


Cramer's Lightning Round - This Is A Great Stock And A Great Company (8/22/13)
8/23/2013 6:03:00 AM - Seeking Alpha


Our BioPharma Catalyst Feature Pick: Auxilium Pharma
8/22/2013 8:31:00 AM - Seeking Alpha


Buy Into Amarin's 1-2-3 Domino Effect
8/18/2013 2:29:00 AM - Seeking Alpha


Positive Data on MannKind's Afrezza - Analyst Blog
8/16/2013 4:20:01 PM - Zacks.com


GlaxoSmithKline Clearing The Clouds Over NCE Prospects Of Amarin's Vascepa
8/15/2013 3:49:00 PM - Seeking Alpha


Amarin: Q2 Results, My Prediction Errors, And The Future: Part II
8/14/2013 11:31:00 AM - Seeking Alpha


Wider-than-Expected Loss at MannKind - Analyst Blog
8/13/2013 8:56:50 AM - Zacks.com


Amarin: Q2 Results, My Prediction Errors, And The Future: Part I
8/9/2013 4:34:00 PM - Seeking Alpha


Amarin's Q2 Shows Large Losses, Prescription Progress
8/8/2013 5:33:00 PM - Seeking Alpha


Amarin: Slow And Steady Wins The Race
8/5/2013 4:17:00 PM - Seeking Alpha


9 Things I'm Curious About For Amarin's Earnings
8/5/2013 12:52:00 PM - Seeking Alpha


Substantial Value Potential In Recently Underperforming Biotechs
8/2/2013 1:21:00 PM - Seeking Alpha


Amarin: How To Actually Read The Prescription Numbers
7/28/2013 7:35:00 AM - Seeking Alpha


Vascepa Scripts Barrel Forward To Q2 Earnings
7/22/2013 10:21:00 AM - Seeking Alpha


Vascepa Scripts Hiccup With Q2 Earnings On Deck
7/19/2013 8:07:00 PM - Seeking Alpha


Amarin's Counterpunch: What Q2 Earnings Could Mean For The Future
7/18/2013 9:32:00 AM - Seeking Alpha


A 1-2 Punch At Amarin Longs
7/15/2013 7:28:00 AM - Seeking Alpha


Amarin Offers American Depositary Shares - Analyst Blog
7/9/2013 5:06:52 PM - Zacks.com


FDA Decisions: Interesting Biotechnology Catalyst Events
7/9/2013 11:04:00 AM - Seeking Alpha